The incidence of ulcerative colitis (UC) increases in
elderly patients. If we include the population diagnosed at a young age and
reaching old age, we will see more and more elderly UC patients day by day. We
need to recognize that elderly patients are a special patient group. Comorbid
diseases and multiple drug use make the management of their diseases more
difficult. When choosing treatment for these patients, we must carefully
balance the clinical condition of the patients and the severity of the immune suppression
we will administer. In order to be successful in the management of this patient
group, branches dealing with comorbid diseases, especially gastroenterology and
geriatrics, must cooperate closely. Treatment changes or newly added
medications should be discussed by relevant specialists.
Atıf Sayısı :